Diabetes Clinical Trials in Michigan

Showing 381-400 of 459 trials

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

NCT00743002

This trial is designed to show the effect of treatment with TT223 or placebo on blood glucose control after 12 weeks of treatment with a 6 month follow-up. TT223 is administered by injection once daily to patients currently treated with Metformin and/or Thiazolidinedione.

Diabetes Mellitus, Type 2

OPKO Health, Inc.87 participantsStarted Aug 2008

Artesia, California, United States • Los Angeles, California, United States • Santa Ana, California, United States +17 more locations

COMPLETEDPhase 270 miles

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT00901979

This study will assess the effect of LCQ when added to metformin.

Type 2 Diabetes Mellitus

Novartis Pharmaceuticals693 participantsStarted Apr 2009

Mesa, Arizona, United States • Mesa, Arizona, United States • Little Rock, Arkansas, United States +64 more locations

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Diabetes Trials in Other Cities

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Resistance Exercise in Already-active Diabetic Individuals (READI) Trial

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

Multicenter Worksite Nutrition Study

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Interferon-Alpha for Diabetes Mellitus Type 1

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Diabetes and Periodontal Therapy Trial

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

Other Conditions in Michigan